Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

1.1K
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.1K
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

1.6K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.6K
Glaucoma: Overview01:25

Glaucoma: Overview

1.6K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prevalence of and risk factors for diabetic retinopathy: The Thessaloniki Eye Study.

Eye (London, England)·2026
Same author

Vision Impairment, Insurance Coverage, and Out-of-Pocket Spending.

JAMA network open·2026
Same author

Visual Electrophysiology for the Diagnosis of Glaucoma: A Report by the American Academy of Ophthalmology.

Ophthalmology·2026
Same author

Baseline risk factors for the development of open-angle glaucoma in a 12-year glaucoma incidence study: the Thessaloniki Eye Study.

The British journal of ophthalmology·2026
Same author

Associations between obesity, metabolic syndrome and glaucoma in the National Institutes of Health 'All of Us' research programme.

The British journal of ophthalmology·2026
Same author

Geographical barriers to surgical treatment for cataract among California Medicare beneficiaries.

Journal of cataract and refractive surgery·2026

Related Experiment Video

Updated: Mar 25, 2026

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents
10:10

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Published on: February 15, 2022

2.0K

Minimally invasive glaucoma surgery: current status and future prospects.

Grace M Richter1, Anne L Coleman2

  • 1UCLA Stein Eye Institute, Department of Ophthalmology, University of California, Los Angeles, CA, USA; USC Eye Institute, Department of Ophthalmology, Keck School of Medicine of University of Southern California, Los Angeles, CA, USA.

Clinical Ophthalmology (Auckland, N.Z.)
|February 13, 2016
PubMed
Summary

Minimally invasive glaucoma surgery offers a safer, medication-sparing alternative for mild-to-moderate glaucoma. These ab interno procedures reduce intraocular pressure with less risk than traditional surgeries.

Keywords:
MIGSSchlemm’s canalab internomicroincisional glaucoma surgerysuprachoroidal shunttrabecular stent

More Related Videos

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation
08:30

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation

Published on: March 12, 2016

13.7K
Ultrasound Cyclo Plasty in Eyes with Glaucoma
05:05

Ultrasound Cyclo Plasty in Eyes with Glaucoma

Published on: January 26, 2018

12.8K

Related Experiment Videos

Last Updated: Mar 25, 2026

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents
10:10

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Published on: February 15, 2022

2.0K
Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation
08:30

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation

Published on: March 12, 2016

13.7K
Ultrasound Cyclo Plasty in Eyes with Glaucoma
05:05

Ultrasound Cyclo Plasty in Eyes with Glaucoma

Published on: January 26, 2018

12.8K

Area of Science:

  • Ophthalmology
  • Surgical Innovation

Background:

  • Glaucoma management traditionally involves medication or incisional surgery.
  • There is a need for safer, less invasive methods to reduce intraocular pressure.
  • Minimally invasive glaucoma surgery (MIGS) offers a conjunctival-sparing, ab interno approach.

Purpose of the Study:

  • To review current minimally invasive glaucoma surgery (MIGS) approaches.
  • To discuss patient selection criteria for MIGS procedures.
  • To examine future expectations for MIGS in glaucoma treatment.

Main Methods:

  • Review of existing data on various MIGS procedures.
  • Discussion of surgical techniques including trabecular outflow enhancement, suprachoroidal shunts, aqueous production reduction, and subconjunctival filtration.
  • Analysis of patient selection factors for optimal outcomes.

Main Results:

  • MIGS encompasses diverse techniques like trabecular bypass stents (iStent, Hydrus), trabeculotomy (Trabectome), suprachoroidal shunts (Cypass), endocyclophotocoagulation, and subconjunctival filtration (XEN).
  • Each approach targets intraocular pressure reduction through different mechanisms.
  • The article synthesizes data and clinical insights on these procedures.

Conclusions:

  • MIGS provides a safer alternative to traditional glaucoma surgery for mild-to-moderate cases.
  • Careful patient selection is crucial for successful MIGS outcomes.
  • MIGS represents a significant advancement in glaucoma treatment, with ongoing innovation expected.